Ekta Batra

Ramesh Kancharla, Chairman and Managing Director of Rainbow Children's Medicare, said the company has largely completed its capacity addition phase after adding more than 700 beds over the last two years.

Jayashree Satagopan, CFO of Sun Pharma expects innovative medicines, specialty therapies and its India business to remain key growth drivers over the next few years, while integration benefits from the Organon acquisition and new manufacturing investments are expected to strengthen long-term global operations.

In an early-stage trial involving 35 high-risk patients, LDL or bad cholesterol fell by up to 62% after a single infusion of the drug, with the effect lasting up to 18 months so far.

Mallanna Sasalu, CEO South at Puravankara says strong technology hiring, improving connectivity corridors and healthy customer demand are supporting Puravankara's expansion plans in Bengaluru, even as the post-pandemic housing frenzy begins to normalise.

Abhay Soi, CMD of Max Healthcare Institute says private equity and institutional capital will remain crucial for expanding India's hospital infrastructure, as the country faces a massive shortage of tertiary care beds amid rising demand for organised healthcare services.

Sarda Energy & Minerals said its power operations have stabilised after planned shutdowns, with stronger seasonal power demand expected to support Q1 FY27 performance as the company advances expansion and debt reduction plans.

Sachin Salgaonkar, Senior Analyst-APAC Telecom, e-commerce at BofA Global Research expects competition in quick commerce to ease over the next few quarters, sees telecom tariffs rising further by 2027, and believes AI-led vernacular and voice commerce could unlock hundreds of millions of new digital users in India.

Nalinikanth Gollagunta, CEO-Automotive Division, M&M said that the company is also seeing strong electric vehicle (EV) momentum, with monthly sales crossing 6,000 units and EV penetration reaching nearly 10% of its portfolio.

Habil F Khorakiwala, Founder & Chairman of Wockhardt Group, said the company continues to see a global peak sales opportunity of $1 billion to $2 billion for Zaynich, with the US market expected to contribute around 40-45% of the overall potential.

David Hauner, Head-Global EM Fixed Income Strategy at BofA Securities, remains structurally bullish on emerging markets over the long term despite near-term headwinds. He expects oil prices to ease, the US dollar to weaken and capital flows to gradually return to emerging market assets next year.